🔎 Trials Near Me

Akèy › Sendwòm myelodisplastik › Utah › Salt Lake City

Etid klinik pou Sendwòm myelodisplastik nan Salt Lake City, UT

8 etid pou Sendwòm myelodisplastik ap chèche patisipan nan sit nan ak bò kote Salt Lake City (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Ap rekriteFaz 2
  • Huntsman Cancer Institute/University of Utah, Salt Lake City
  • George E Wahlen Department of Veterans Affairs Medical Center, Salt Lake City
Laj 18 ak plis · Tout sèks · Mizajou Oct 5, 2026 · NCT05564390

Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)

Ap rekriteFaz 2
  • Huntsman Cancer Institute/University of Utah, Salt Lake City
Laj 18 ak plis · Tout sèks · Mizajou Oct 5, 2026 · NCT06577441

A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions

Ap rekriteFaz 3
  • Huntsman Cancer Institute, Salt Lake City
Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT07422480

Study of R289 in Patients With Lower-risk Myelodysplastic Syndromes (LR MDS)

Ap rekriteFaz 1/2
  • Intermountain Healthcare, Salt Lake City
Laj 18 ak plis · Tout sèks · Mizajou Aug 10, 2026 · NCT05308264

Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer

Ap rekrite
  • George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City
Laj 18 ak plis · Tout sèks · Mizajou Apr 30, 2026 · NCT05297734

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

Ap rekriteFaz 1/2
  • Huntsman Cancer Institute, Salt Lake City
  • Intermountain Healthcare, Salt Lake City
Laj 12 ak plis · Tout sèks · Mizajou Mar 24, 2026 · NCT04988555

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Ap rekriteEtid obsèvasyon
  • Massive Bio SYNERGY-AI site, Salt Lake City
Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774

Etid Sendwòm myelodisplastik nan lòt vil

Lòt etid nan Salt Lake City

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.